TITLE

Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer

AUTHOR(S)
Keam, Bhumsuk; Im, Seock-Ah; Lim, Yoojoo; Han, Sae-Won; Moon, Hyeong-Gon; Oh, Do-Youn; Cho, Nariya; Lee, Se-Hoon; Han, Wonshik; Moon, Woo; Kim, Dong-Wan; Kim, Tae-You; Park, In; Noh, Dong-Young
PUB. DATE
July 2013
SOURCE
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jul2013, Vol. 20 Issue 7, p2242
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88005760

 

Related Articles

  • American Joint Committee on Cancer Tumor—Node—Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome. Carey, Lisa A.; Metzger, Richard; Dees, E. Claire; Collichio, Frances; Sartor, Carolyn I.; Ollila, David W.; Klauber-Demore, Nancy; Halle, Jan; Sawyer, Lynda; Moore, Dominic T.; Graham, Mark L. // JNCI: Journal of the National Cancer Institute;8/3/2005, Vol. 97 Issue 15, p1137 

    Background: Response to neoadjuvant chemotherapy is used as an intermediate endpoint for breast cancer relapse and survival. Most breast cancer response classification systems use pathologic complete response, either alone or in conjunction with clinical assessments, to categorize response. We...

  • Treatment - Neoadjuvant and Adjuvant Therapy.  // Current Medical Literature: Breast Cancer;2010, Vol. 22 Issue 3, p101 

    The article discusses research on breast cancer treatment with neoadjuvant and adjuvant therapy. A study by M. D. Holmes et al published in the "Journal of Clinical Oncology" focused on the use of aspirin in breast cancer treatment among women. A study by T. Byrski et al published in the...

  • Can Early Response Assessment Guide Neoadjuvant Chemotherapy in Early-Stage Breast Cancer? Esteva, Francisco J.; Hortobagyia, Gabriel N. // JNCI: Journal of the National Cancer Institute;4/16/2008, Vol. 100 Issue 8, p521 

    The author reflects about early response assessments and whether they can help neoadjuvant chemotherapy in early-stage breast cancer treatment. According to the article, studies inquiring about neoadjuvant chemotherapy among women with operable breast cancer started after the success of...

  • Clinical Efficacy of Including Capecitabine in Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Qiuyun Li; Yi Jiang; Wei Wei; Huawei Yang; Jianlun Liu // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background: Capecitabine has proven effective as a chemotherapy for metastatic breast cancer. Though several Phase II/III studies of capecitabine as neoadjuvant chemotherapy have been conducted, the results still remain inconsistent. Therefore, we performed a meta-analysis to obtain more precise...

  • Erratum: Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.  // World Journal of Nuclear Medicine;Jan-Apr2016, Vol. 15 Issue 1, p75 

    A correction to the article "Role of Scintimammography in Assessing the Response of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer" that was published in the 2014 issue is presented.

  • EVALUATION OF CLINICAL AND PATHOLOGICAL RESPONSE AFTER TWO CYCLES OF NEOADJUVANT CHEMOTHERAPY ON SUDANESE PATIENTS WITH LOCALLY ADVANCED BREAST CANCER. Alawad, Awad Ali M. // Ethiopian Journal of Health Sciences;Jan2014, Vol. 24 Issue 1, p15 

    BACKGROUND: The use of neoadjuvant chemotherapy in treating breast cancer has shown efficacy in downstaging primary tumors, and allows breast conservative surgery to be performed instead of mastectomy. This study aims to evaluate patterns of clinical and pathological response after two cycles of...

  • Breast.  // Modern Pathology;Jan2006 Supplement 1, Vol. 19, p19A 

    The article presents abstracts of breast cancer research. They include "Chromosomal Alterations in Hyperplastic Regions in the Breast Depend Upon the Presence of Coexisting Cancer," "Prediction of Pathologic Response Based on Clinical-Pathologic Features in Breast Cancer With Neoadjuvant...

  • Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.  // BMC Cancer;2012, Vol. 12 Issue 1, p39 

    The article discusses a study which examined the tumor metabolic changes in patients with locally advanced breast cancer caused by neoadjuvant chemotherapy (NAC), relating these changes to clinical treatment response and long-term survival. The study concluded that the differences in tumor...

  • Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR). Jisun Kim; Woosung Lim; Eun-Kyu Kim; Min-Kyoon Kim; Nam-Sun Paik; Sang-Seol Jeong; Jung-han Yoon; Chan Heun Park; Sei Hyun Ahn; Lee Su Kim; Sehwan Han; Seok Jin Nam; Han-Sung Kang; Seung Il Kim; Young Bum Yoo; Joon Jeong; Tae Hyun Kim; Taewoo Kang; Sung-Won Kim; Yongsik Jung // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background: Neoadjuvant endocrine therapy with an aromatase inhibitor has shown efficacy comparable to that of neoadjuvant chemotherapy in patients with postmenopausal breast cancer. Preclinical and clinical studies have shown that the antidiabetic drug metformin has anti-tumor activity. This...

  • Breast conservation after induction chemotherapy for... Kling, Karen Michiko; Ostrzega, Nora // American Surgeon;Oct1997, Vol. 63 Issue 10, p861 

    Evaluates the eligibility of patients with locally advanced noninflammatory breast cancer for breast conservation after undergoing neoadjuvant chemotherapy (NC). Clinical importance of NC; Several results of report about the patients' response rates with NC; Percentage of the study group...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics